Belpointe Asset Management LLC Theratechnologies Inc. Transaction History

Belpointe Asset Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.01 $4,208 - $5,448	-5,395 Reduced 12.44%	37,983 $31,000
Q1 2023 May 15, 2023	SELL	$0.72 - $1.12 $41 - $64	-58 Reduced 0.13%	43,378 $35,000
Q3 2022 Nov 14, 2022	BUY	$1.98 - $2.42 $86,003 - $105,115	43,436 New	43,436 $103,000
Q2 2022 Aug 02, 2022	SELL	$2.21 - $2.7 $95,993 - $117,277	-43,436 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$2.37 - $3.24 $55,403 - $75,741	-23,377 Reduced 34.99%	43,436 $106,000
Q4 2021 Feb 15, 2022	SELL	$2.92 - $3.76 $292 - $376	-100 Reduced 0.15%	66,813 $202,000
Q3 2021 Nov 15, 2021	SELL	$3.28 - $4.07 $5,703 - $7,077	-1,739 Reduced 2.53%	66,913 $251,000
Q1 2021 May 14, 2021	SELL	$2.2 - $3.94 $3,498 - $6,264	-1,590 Reduced 2.26%	68,652 $265,000
Q3 2020 Nov 13, 2020	SELL	$1.96 - $2.92 $11,952 - $17,806	-6,098 Reduced 7.99%	70,242 $155,000
Q3 2020 Nov 13, 2020	BUY	$1.96 - $2.92 $750 - $1,118	383 Added 0.5%	76,340 $122,000
Q2 2020 Jul 20, 2020	SELL	$1.58 - $2.86 $605 - $1,095	-383 Reduced 0.5%	75,957 $153,000
Q1 2020 Jul 20, 2020	SELL	$1.43 - $3.23 $8,266 - $18,672	-5,781 Reduced 7.04%	76,340 $122,000
Q4 2019 Feb 18, 2020	BUY	$2.74 - $4.2 $225,011 - $344,908	82,121 New	82,121 $271,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $114M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.